Gene Therapy
Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.
131 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 1 |
BlackRock
New York
| $6.04B | -$844M | 87 | 0.12% | Reduced |
|
| 2 |
Vanguard Group
Malvern,
Pennsylvania
| $5.22B | -$1.06B | 85 | 0.09% | Reduced |
|
| 3 |
Fidelity Investments
Boston,
Massachusetts
| $2.83B | -$251M | 69 | 0.17% | Reduced |
|
| 4 |
State Street
Boston,
Massachusetts
| $2.42B | -$477M | 82 | 0.1% | Reduced |
|
| 5 |
Wellington Management Group
Boston,
Massachusetts
| $2.19B | -$176M | 32 | 0.4% | Reduced |
|
| 6 |
SVGI
Sozo Ventures GP II
Redwood City,
California
| $2.1B | $0 | 1 | 100% | Maintained |
|
| 7 |
Capital International Investors
Los Angeles,
California
| $1.48B | +$335M | 5 | 0.28% | Increased |
|
| 8 |
Morgan Stanley
New York
| $1.41B | -$12.8M | 94 | 0.1% | Reduced |
|
| 9 |
Janus Henderson Group
London,
| $1.37B | -$43.5M | 22 | 0.7% | Reduced |
|
| 10 |
Dimensional Fund Advisors
Austin,
Texas
| $1.26B | +$18M | 41 | 0.3% | Increased |
|
| 11 |
Geode Capital Management
Boston,
Massachusetts
| $1.22B | -$237M | 96 | 0.09% | Reduced |
|
| 12 |
Dodge & Cox
San Francisco,
California
| $1.19B | -$769K | 1 | 0.69% | Reduced |
|
| 13 |
Primecap Management
Pasadena,
California
| $1.18B | -$109M | 5 | 0.91% | Reduced |
|
| 14 |
GS
Gilead Sciences
Foster City,
California
| $995M | +$1.07B | 4 | 64.15% | New |
|
| 15 |
Bank of America
Charlotte,
North Carolina
| $888M | -$274M | 95 | 0.07% | Reduced |
|
| 16 |
Avoro Capital Advisors
New York
| $869M | +$31.7M | 7 | 12.29% | Increased |
|
| 17 |
T. Rowe Price Associates
Baltimore,
Maryland
| $837M | -$225M | 47 | 0.1% | Reduced |
|
| 18 |
RTW Investments
New York
| $811M | -$26.6M | 10 | 12.26% | Reduced |
|
| 19 |
Franklin Resources
San Mateo,
California
| $799M | -$2.03M | 27 | 0.22% | Reduced |
|
| 20 |
Goldman Sachs
New York
| $768M | +$12M | 74 | 0.12% | Increased |
|
| 21 |
UBS Group
Zurich,
Switzerland
| $755M | +$397M | 97 | 0.14% | Increased |
|
| 22 |
Invesco
Atlanta,
Georgia
| $729M | -$155M | 45 | 0.13% | Reduced |
|
| 23 |
Northern Trust
Chicago,
Illinois
| $709M | +$10.1M | 80 | 0.1% | Increased |
|
| 24 |
Kohlberg Kravis Roberts & Co
New York
| $693M | $0 | 1 | 18.56% | Maintained |
|
| 25 |
Viking Global Investors
Stamford,
Connecticut
| $689M | $0 | 1 | 2.23% | Maintained |
|